AllerEzy Supplement Explained — 8-Ingredient Science Behind Seasonal Immune and Respiratory Support
How to Evaluate a Seasonal Wellness Supplement: A 4-Mechanism Scientific Framework
An evidence-based scientific guide to AllerEzy's multi-ingredient formula — examining 4 biological mechanisms and 8 scientifically contextualized ingredients for seasonal wellness and immune support.
Published: March 26, 2026 Written by Nalin Siriwardhana, PhD, FACN Published by NUTRITUNES® Science of Supplements
This article is for educational purposes and is grounded in peer-reviewed scientific literature cited throughout. Individual responses to dietary supplements vary.
Compliance note: This article discusses biological processes associated with seasonal environmental immune responses and does not imply that any dietary supplement can diagnose, treat, cure, or prevent disease.
At a glance: A well-designed seasonal wellness formula should address more than one biological pathway. The strongest supplement labels typically combine histamine-modulating ingredients, respiratory tissue support, immune-modulating compounds, and foundational micronutrients — each in disclosed, clinically contextualized doses.
The Case for a Layered Seasonal Wellness Approach
The body's response to environmental triggers — pollen, dust, pet dander — does not arrive as a single problem. It involves a cascade of overlapping biological events: mast cells releasing histamine, airway tissue becoming inflamed, the mucosal immune barrier losing equilibrium, and micronutrient-dependent immune processes operating below optimal levels. Single-ingredient approaches often do not reflect the biological complexity of seasonal immune responses, which involve multiple overlapping pathways.
What the published research supports is a layered nutritional approach: one that combines botanicals studied in relation to histamine balance, enzymes associated with respiratory tissue comfort, postbiotics with documented immune-modulating properties, and foundational micronutrients that support immune competence. That is the scientific logic behind multi-ingredient seasonal wellness formulas — and the framework used here to evaluate AllerEzy.
This article focuses on mechanisms, ingredient forms, dosage context, and the strength of the available evidence.
Quick Selection Checklist: What to Look for on the Label
- Butterbur standardized to petasins (≥15%) and explicitly labeled PA-free
- Quercetin as quercetin dihydrate (higher solubility than anhydrous forms)
- Bromelain activity rated in GDU/g — not just milligrams
- EpiCor® or a similarly studied branded yeast fermentate postbiotic at ≥500 mg
- Vitamin C at 100% DV minimum; Vitamin D as cholecalciferol (D3)
- Zinc as zinc citrate or picolinate; Selenium as selenomethionine
- GMP-certified manufacturing in an FDA-registered facility
- No proprietary blends that obscure individual ingredient doses
If you remember one thing: A layered formula may offer broader nutritional support than a single-ingredient product because it is designed to support multiple biological pathways simultaneously — though no supplement replaces a medical evaluation for clinically significant health concerns.
Who This May Be For
This article is written for adults seeking to understand the science behind nutritional support for year-round or seasonal immune and respiratory wellness. It may be particularly relevant for those who prefer non-drowsy, non-pharmaceutical nutritional approaches as a complement to a healthy lifestyle — or who want to evaluate what the available evidence says before choosing a supplement. It is not medical advice, and it is not a substitute for evaluation by a licensed healthcare provider.
4 Key Mechanisms — 8 Scientifically Selected Ingredients
The AllerEzy formula is designed to map across four distinct physiological parameters. Each section below explains why that parameter matters biologically, identifies the relevant ingredient(s), their specific forms and doses, and offers an honest assessment of the published evidence.
Mechanism 1 — Histamine Balance: Quercetin Dihydrate + Bromelain
Why it matters: When the immune system encounters allergens or environmental triggers, mast cells and basophils may degranulate, releasing histamine and other pro-inflammatory mediators. This cascade underlies the nasal congestion, sneezing, and respiratory tissue responses characteristic of allergic rhinitis and related seasonal immune conditions. Supporting healthy mast cell signaling is a primary focus in nutritional science related to seasonal immune wellness.
Ingredients: Quercetin dihydrate 95% extract (250 mg) + Bromelain 2400 GDU/g (250 mg)
Quercetin is among the most studied flavonoids in immune and allergy biology. A widely cited 2016 review in Molecules (PMID 27187333) — examining quercetin's role across allergic and inflammatory immune pathways — found that quercetin was associated with inhibition of histamine release from mast cells, suppression of pro-inflammatory cytokines including IL-4 and leukotrienes, and modulation of the Th1/Th2 immune balance. The authors discussed these mechanisms specifically in the context of allergic rhinitis and atopic conditions. A comparative study in PLOS ONE (PMC3314669), conducted using cultured human mast cells, reported that quercetin inhibited histamine and IL-8 release more effectively than cromolyn — a compound formally used as a mast cell stabilizer in allergy management. A 2025 narrative review in Nutrients (PMID 40362785), focused on quercetin's applications across allergic diseases including allergic rhinitis, atopic dermatitis, and asthma, further described quercetin's observed action across IgE-dependent and IgE-independent mast cell degranulation pathways. It is important to note that while mechanistic and cell-level evidence is substantial, controlled human clinical data for seasonal allergic respiratory outcomes specifically remains more limited than the in vitro and animal evidence base.
Bromelain, derived from the pineapple stem, plays a complementary role. It is associated with modulation of prostaglandin and leukotriene synthesis pathways, and has been suggested in some experimental models to support enhanced quercetin absorption across the intestinal epithelium. A pharmacokinetic study in Acta Otorhinolaryngologica Italica (PMC6036946) — enrolling patients with chronic rhinosinusitis — found that orally administered bromelain penetrated measurably into sinonasal mucosal tissue in both patients and controls, with statistically significant distribution from serum to turbinate and ethmoid mucosa, suggesting systemic distribution to the upper respiratory tissue compartment. A pilot observational study (PMID 24273953), conducted in patients with chronic rhinosinusitis with and without nasal polyps, found that bromelain supplementation was associated with improvements in total symptom scores, rhinoscopy scores, and quality-of-life measures as assessed by the SNOT-20 questionnaire, with no adverse events observed over a three-month period.
Evidence grade: Quercetin — Moderate to strong mechanistic support; strong cell and animal evidence; limited controlled human evidence for seasonal respiratory-specific endpoints. Bromelain — Moderate (human pilot studies + pharmacokinetic data).
What to look for: Quercetin dihydrate (not rutin or standard quercetin glycosides); Bromelain rated in GDU activity units rather than mass alone.
Key takeaway: Quercetin and bromelain are studied for their roles in histamine balance and mucosal tissue support from complementary biological angles, and are often used together due to their mechanistically complementary profiles. → [Learn more: Understanding the Histamine Response]
References to clinical research describe published study findings and are provided for scientific context. They do not constitute claims about what any NUTRITUNES® product will do for any individual.
Mechanism 2 — Respiratory Comfort: PA-Free Butterbur (Petasites hybridus)
Why it matters: Allergic rhinitis — the clinical term for the immune-mediated nasal response to environmental triggers — involves mast cell activation and eosinophilic infiltration of nasal epithelium. The sesquiterpene compounds in butterbur root, known as petasins, have been studied in relation to their potential to support healthy nasal and upper respiratory tissue responses, possibly through leukotriene and prostaglandin pathway interactions.
Ingredient: Butterbur root extract (75 mg, standardized to 15% petasins, PA-free)
The National Center for Complementary and Integrative Health (NCCIH) summarizes the human evidence as follows: studies of butterbur leaf or root extracts suggest they may be helpful for symptoms of allergic rhinitis when taken orally. A 2007 systematic review of six randomized controlled trials — all conducted in populations with intermittent allergic rhinitis — reported that butterbur was associated with nasal symptom score improvements comparable to, or exceeding, placebo and in some trials similar to non-sedating antihistamines. The NCCIH notes, however, that three of the large trials reviewed had manufacturer financial involvement, warranting cautious interpretation of their findings.
A widely referenced RCT in the BMJ (Schapowal et al., 2002, PMID 11799030) — a study conducted in patients with seasonal allergic rhinitis — found that a standardized butterbur root extract was associated with symptom score outcomes comparable to cetirizine, a non-sedating antihistamine used in allergic rhinitis management, without causing sedation. This remains one of the more cited human clinical observations in the butterbur research literature.
Critical safety note: Raw butterbur contains pyrrolizidine alkaloids (PAs), which the NCCIH identifies as potentially hepatotoxic. Only PA-free preparations should be considered for use. AllerEzy's label explicitly specifies that its extract is PA-free and standardized to 15% petasins — both essential quality markers. The published safety profile for PA-free butterbur extends to approximately 16 weeks; data on longer-term use remains limited, which is a limitation the research community openly acknowledges. Individuals with liver conditions or those taking hepatically metabolized medications should consult a healthcare professional before use.
Evidence grade: Moderate for upper respiratory comfort-related endpoints in published studies (human RCT data exists, with conflict-of-interest caveats noted); acceptable short-term safety profile when PA-free and within a 16-week use period.
What to look for: "PA-free" or "free from Pyrrolizidine Alkaloids" on the label; standardized petasin content ≥15%.
Key takeaway: PA-free, petasin-standardized butterbur has one of the more studied clinical records among botanicals in the seasonal respiratory wellness category — with the important caveats that preparation quality, study independence, and use-period limits all matter.
Mechanism 3 — Mucosal Immune Support: EpiCor® Postbiotic
Why it matters: The immune calibration relevant to environmental challenges is not isolated to the nasal passages. A well-functioning mucosal immune system — including secretory IgA production, NK cell activity, and Th1/Th2 balance — is central to how the body responds to seasonal environmental exposures. The gut-immune axis is an active and growing area of nutritional research, and postbiotics offer a stable, well-characterized approach to supporting it.
Ingredient: EpiCor® postbiotic from Saccharomyces cerevisiae (500 mg)
EpiCor is among the better-studied branded postbiotic ingredients used in dietary supplements, with over 15 published clinical and mechanistic studies. A 12-week randomized, double-blind, placebo-controlled trial (Moyad et al., Urology Nursing, 2008, PMID 18335698) — conducted in healthy adults recently vaccinated for seasonal influenza — reported that subjects receiving 500 mg/day of EpiCor had significantly fewer cold and flu-like symptoms and significantly shorter duration of symptoms compared to placebo over the 12-week study period. A crossover pilot study (Jensen et al., J Med Food, 2011, PMID 21501093), enrolling healthy adult subjects, reported that a single 500 mg dose of EpiCor was associated with measurable changes in circulating immune cell populations — including NK cell counts and T-cell distribution — and cytokine profiles within 2 hours of consumption compared to placebo.
A 2024 RCT in Pediatric Research (PMID 38942887) — conducted over 84 days in 256 healthy children aged 4–12 attending school or daycare during the 2022–23 flu season — reported that the EpiCor group had significantly lower total cold/flu symptom severity scores and reduced cold/flu medication usage compared to placebo, with good tolerability throughout. A 2024 in vitro gut model study (Frontiers in Microbiology, PMC10895063) found EpiCor was associated with increased Bifidobacterium abundance and improvements in mucosal barrier function markers in a simulated human intestinal model — offering a mechanistic link between gut microbiome modulation and immune-related outcomes. Additionally, a 12-week double-blind, placebo-controlled trial in 96 subjects with seasonal allergic rhinitis reported that the EpiCor group showed reduced severity of nasal congestion and rhinorrhea compared to placebo over the allergy season.
The ingredient has supportive human and mechanistic data across immune and gut-health-related endpoints. Direct evidence specific to allergic rhinitis outcomes is more limited than its broader immune evidence base — a distinction worth holding when evaluating this ingredient's role in a seasonal wellness formula.
Evidence grade: Strong for general mucosal immune support at the 500 mg dose (multiple human RCTs with consistent findings); moderate for seasonal respiratory-specific endpoints.
What to look for: EpiCor® (trademarked; Non-GMO Project Verified, FDA GRAS, NSF Certified); 500 mg dose from Saccharomyces cerevisiae.
Key takeaway: EpiCor's dose in AllerEzy represents a strong alignment between published clinical dosing and label inclusion — and its broader immune-support data is among the most consistent in its ingredient category. Direct evidence for allergic rhinitis-specific endpoints, while emerging, warrants continued study. → [Learn more: What Is a Postbiotic? EpiCor and the Science of Yeast Fermentates]
Mechanism 4 — Micronutrient Sufficiency: Vitamin C, Vitamin D3, Zinc Citrate, Selenomethionine
Why it matters: Immune competence at the mucosal and systemic level depends on adequate micronutrient status. These four micronutrients support the front-line immune response — epithelial barrier integrity, innate immune signaling, and lymphocyte activity — and are among the most well-established in the nutritional immunology literature. Benefits in any individual may depend on baseline nutrient status, making dietary sufficiency context important.
Ingredients and doses: Vitamin C (90 mg, 100% DV, as ascorbic acid) + Vitamin D (20 mcg, 100% DV, as cholecalciferol) + Zinc (2.75 mg, 25% DV, as zinc citrate) + Selenium (13.75 mcg, 25% DV, as selenomethionine)
Vitamin C is associated with neutrophil function, mucosal antioxidant defense, and immune cell co-factor activity. Vitamin D3 (cholecalciferol — the preferred bioavailable form over ergocalciferol/D2) has been studied in relation to adaptive immune regulation and respiratory tissue responses. Zinc, delivered here as zinc citrate for its bioavailability advantage over zinc oxide, is associated with T-cell development, zinc-finger transcription factor activity in immune gene regulation, and mast cell biology. Selenium as selenomethionine — the organic, well-absorbed form — supports selenoprotein synthesis, including glutathione peroxidase enzymes involved in mucosal oxidative defense.
At the doses included in AllerEzy, Vitamin C and D are delivered at 100% of the Daily Value — appropriate as a daily nutritional baseline. Zinc and Selenium are included at 25% DV as complementary contributions, appropriate for a comprehensive multi-ingredient formula. These are foundational nutritional support doses, not high-dose therapeutic regimens.
Evidence grade: Strong — each micronutrient's role in immune function is well-established across nutritional immunology meta-analyses and mechanistic RCTs. Functional benefit in individuals with dietary sufficiency may be less pronounced than in those with suboptimal baseline intake.
What to look for: Vitamin D as cholecalciferol (D3, not ergocalciferol/D2); Zinc as citrate or picolinate (not oxide); Selenium as selenomethionine (not inorganic selenite); transparent individual doses.
Key takeaway: These four micronutrients provide the immune scaffolding that botanical ingredients depend on to function in context. Their inclusion in bioavailable forms reflects formulation intentionality, with the caveat that individual benefit may vary based on dietary baseline.
How AllerEzy Maps to This Evidence Framework
| Ingredient | Dose | Form | Evidence-Based Context | Honest Notes |
|---|---|---|---|---|
| Quercetin | 250 mg | Dihydrate 95% extract | Studied for histamine balance and mast cell signaling | Strong mechanistic; limited direct human seasonal data |
| Bromelain | 250 mg | 2400 GDU/g | Associated with mucosal tissue support; quercetin absorption synergy suggested | GDU activity rating more meaningful than mass |
| EpiCor® | 500 mg | S. cerevisiae postbiotic | Matches exact RCT dose; multiple human trials across immune endpoints | Broader general immune evidence than seasonal-specific |
| Butterbur | 75 mg | 15% petasins; PA-free | Studied for upper respiratory comfort outcomes | 16-week safety window; PA-free essential; some trial COI |
| Vitamin C | 90 mg (100% DV) | Ascorbic acid | Foundational mucosal immune and antioxidant support | 100% DV; benefit depends on baseline status |
| Vitamin D | 20 mcg (100% DV) | Cholecalciferol (D3) | Preferred bioavailable form; studied for immune regulation | 100% DV; well-established immune role |
| Zinc | 2.75 mg (25% DV) | Zinc citrate | T-cell and immune signaling support | Bioavailable form; 25% DV complementary dose |
| Selenium | 13.75 mcg (25% DV) | Selenomethionine | Selenoprotein and mucosal antioxidant support | Organic form; 25% DV complementary dose |
AllerEzy includes several ingredients at doses that align with commonly studied ranges or branded clinical-use levels. Vitamin D and Zinc are supplementary rather than therapeutic stand-alone doses — appropriate for a comprehensive daily formula. Limitations to hold: butterbur's evidence base is moderate with some conflict-of-interest considerations in key trials; EpiCor's seasonal-specific data is more limited than its general immune data; and quercetin's human evidence for seasonal respiratory outcomes specifically remains an area for further study. No supplement delivers guaranteed outcomes, and individual responses vary.
Summary Table: Evidence-Based Standard vs. AllerEzy
| Criterion | Evidence-Based Standard | AllerEzy |
|---|---|---|
| Quercetin form | Dihydrate (solubility advantage) | Quercetin dihydrate 95% ✓ |
| Bromelain specification | GDU-rated activity | 2400 GDU/g ✓ |
| Butterbur safety | PA-free, petasin-standardized | PA-free; 15% petasins ✓ |
| Postbiotic dose | 500 mg (RCT-validated) | 500 mg EpiCor® ✓ |
| Vitamin D form | Cholecalciferol (D3) | Cholecalciferol ✓ |
| Zinc form | Citrate or picolinate | Zinc citrate ✓ |
| Selenium form | Selenomethionine (organic) | Selenomethionine ✓ |
| Manufacturing | GMP; FDA-registered | GMP-compliant; made in USA ✓ |
FAQ
Q: Is AllerEzy a replacement for antihistamine or allergy medications? No. AllerEzy is a dietary supplement formulated to support healthy histamine levels, respiratory comfort, and immune function through nutritional means. It is not a drug and is not intended to replace prescription or over-the-counter medications. Individual responses vary. A licensed healthcare provider is the appropriate person to guide medication-related decisions.
Q: What makes EpiCor® different from a standard probiotic? EpiCor is a postbiotic — a heat-inactivated preparation of Saccharomyces cerevisiae and its metabolites, not a live microbial culture. Postbiotics carry no risk of intestinal translocation or antibiotic resistance concerns. EpiCor has FDA GRAS status, NSF certification, and is among the better-studied postbiotic ingredients used in supplements, with over 15 published human or mechanistic studies at the 500 mg dose included in AllerEzy.
Q: Why does the butterbur in AllerEzy specify "PA-free"? Raw butterbur contains pyrrolizidine alkaloids (PAs), which the NCCIH identifies as potentially hepatotoxic. PA-free certification — alongside the 15% petasin standardization on AllerEzy's label — distinguishes formulation-grade preparations from unprocessed butterbur. For any butterbur supplement, these are the two non-negotiable quality markers.
Q: What does "quercetin dihydrate 95% extract" mean, and why does it matter? Quercetin dihydrate is a specific molecular form with improved aqueous solubility compared to anhydrous quercetin, which is relevant to absorption. The 95% extract designation reflects the purity of the quercetin fraction — a higher-grade specification than many standard quercetin powders on the market.
Q: How does bromelain's activity rating (2400 GDU/g) matter? GDU — Gelatin Digesting Units per gram — measures enzymatic activity, not just mass. Two bromelain products at identical weights can deliver very different functional potency depending on their GDU rating. 2400 GDU/g is a high-activity specification and more meaningful than milligram weight alone when evaluating bromelain quality.
Q: Can I take AllerEzy year-round? AllerEzy is formulated for daily nutritional support. The published safety data for PA-free butterbur extends to approximately 16 weeks. For extended or year-round use, consultation with a licensed healthcare provider is advisable — particularly for individuals with liver conditions or who take medications metabolized hepatically.
Q: Should I consult a clinician before starting this supplement? Yes — particularly if you are pregnant or breastfeeding, take prescription medications (including blood thinners, as bromelain has been associated with anticoagulant interactions), or have a history of liver, thyroid, or immune-mediated health conditions. In high supplemental doses, quercetin has been noted in some literature to warrant monitoring in individuals with thyroid conditions.
Q: What should I look for on any seasonal wellness supplement label to assess quality? Transparent individual ingredient doses (no proprietary blends), standardized botanical extracts with form-specific notation, GMP manufacturing in an FDA-registered facility, third-party certifications (NSF, Non-GMO Project), and bioavailable mineral forms (citrate or picolinate over oxide; selenomethionine over inorganic selenite).
When to Talk to a Clinician
Dietary supplements are not a substitute for a medical evaluation. Seek professional guidance if you are experiencing symptoms that are severe, persistent, or affecting daily functioning; if you take prescription medications; if you are pregnant or nursing; or if you have a history of liver disease, autoimmune conditions, or known drug-supplement interactions. A clinician familiar with integrative or nutritional medicine can help assess what role, if any, a supplement like AllerEzy may play as part of a broader wellness strategy.
The Bottom Line
The biological complexity of the body's response to seasonal environmental challenges is multilayered. A well-designed nutritional formula should reflect that complexity. The strongest case for a layered seasonal wellness supplement rests on supporting histamine signaling pathways, upper respiratory tissue comfort, mucosal immune function, and foundational micronutrient status in parallel — with ingredient forms and doses grounded in the published scientific literature.
AllerEzy is formulated to support these biological pathways through quercetin and bromelain for histamine balance and mucosal tissue support, PA-free standardized butterbur for upper respiratory comfort, EpiCor postbiotic at the 500 mg clinically studied dose for mucosal immune support, and four foundational micronutrients in their bioavailable forms. It is produced in a GMP-compliant, FDA-registered U.S. facility. No single supplement addresses every aspect of health — and no credible science article would suggest otherwise. Used as a complement to sound nutrition, adequate sleep, and appropriate clinical care, AllerEzy reflects a formula architecture grounded in mechanism-first thinking.
→ [Explore AllerEzy – Product Page] → [Understanding the Histamine Response – Related Article] → [What Is a Postbiotic? EpiCor and the Science of Yeast Fermentates – Related Article] → [Seasonal Wellness: A Year-Round Nutritional Framework – Related Article] → [NUTRITUNES Science of Supplements Hub]
References
- Mlcek J, Jurikova T, Skrovankova S, Sochor J. Quercetin and Its Anti-Allergic Immune Response. Molecules. 2016;21(5):623. PMID: 27187333. https://pubmed.ncbi.nlm.nih.gov/27187333/
- Weng Z, Zhang B, Asadi S, et al. Quercetin Is More Effective than Cromolyn in Blocking Human Mast Cell Cytokine Release and Inhibits Contact Dermatitis and Photosensitivity in Humans. PLOS ONE. 2012;7(3):e33805. PMC3314669. https://pmc.ncbi.nlm.nih.gov/articles/PMC3314669/
- Otreba M, Bołdys A. Quercetin and Its Lecithin-Based Formulation: Potential Applications for Allergic Diseases Based on a Narrative Review. Nutrients. 2025;17(9):1476. PMID: 40362785. https://pubmed.ncbi.nlm.nih.gov/40362785/
- De Luca P, et al. Bromelain's penetration into the blood and sinonasal mucosa in patients with chronic rhinosinusitis. Acta Otorhinolaryngol Ital. 2018;38(3):200–204. PMC6036946. https://pmc.ncbi.nlm.nih.gov/articles/PMC6036946/
- Ridolo E, et al. Efficacy and tolerability of bromelain in patients with chronic rhinosinusitis — a pilot study. Rhinology. 2013;52(1):191. PMID: 24273953. https://pubmed.ncbi.nlm.nih.gov/24273953/
- Schapowal A; Petasites Study Group. Randomised controlled trial of butterbur and cetirizine for treating seasonal allergic rhinitis. BMJ. 2002;324(7330):144–146. PMID: 11799030. https://pubmed.ncbi.nlm.nih.gov/11799030/
- National Center for Complementary and Integrative Health (NCCIH). Butterbur: Usefulness and Safety. https://www.nccih.nih.gov/health/butterbur
- NCCIH Clinical Digest. Seasonal Allergies and Complementary Health Approaches: What the Science Says. https://www.nccih.nih.gov/health/providers/digest/seasonal-allergies-and-complementary-health-approaches-science
- Moyad MA, Robinson LE, Zawada ET Jr, et al. Effects of a modified yeast supplement on cold/flu symptoms. Urol Nurs. 2008;28(1):50–55. PMID: 18335698. https://pubmed.ncbi.nlm.nih.gov/18335698/
- Jensen GS, Redman KA, Benson KF, et al. Antioxidant bioavailability and rapid immune-modulating effects after consumption of a single acute dose of a high-metabolite yeast immunogen. J Med Food. 2011;14(9):1002–1010. PMID: 21501093. https://pubmed.ncbi.nlm.nih.gov/21501093/
- Conti V, et al. Efficacy of a yeast postbiotic on cold/flu symptoms in healthy children: A randomized-controlled trial. Pediatr Res. 2024. PMID: 38942887. https://pubmed.ncbi.nlm.nih.gov/38942887/
- Possemiers S, et al. Saccharomyces cerevisiae derived postbiotic alters gut microbiome metabolism in the human distal colon resulting in immunomodulatory potential in vitro. Front Microbiol. 2024;15:1358456. PMC10895063. https://pmc.ncbi.nlm.nih.gov/articles/PMC10895063/
- Jensen GS, et al. A dried yeast fermentate prevents and reduces inflammation in two separate experimental immune models. J Med Food. 2012;15(4):367–374. PMC3328167. https://pmc.ncbi.nlm.nih.gov/articles/PMC3328167/
- Guo Z, et al. Quercetin a promising functional food additive against allergic diseases: A comprehensive and mechanistic review. Food Bioscience. 2024. https://www.sciencedirect.com/science/article/pii/S1756464624001543
FDA Disclaimer
These statements have not been evaluated by the Food and Drug Administration. NUTRITUNES® supplements are dietary supplements and are not intended to diagnose, treat, cure, or prevent any disease or health condition. Individual responses to dietary supplements vary.
If you are experiencing symptoms requiring medical evaluation, consult a licensed healthcare professional promptly.